In the present work, Zn(II), Co(II) and Cr(II) metal complexes (3-5) of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine ligand (2) were synthesized and their anti-HIV activity by inhibiting reverse transcriptase was explored. Structural characterization using NMR, FTIR, Mass, UV-Vis spectra, TGA, magnetic moment and elemental analyses were performed. The analyses show that geometry, lipophilicity and steric factor play crucial role. Cell viability test is performed on peripheral blood mononuclear cells to check toxicity of prepared compounds on immune system, shows toxicity only at higher concentration. Antimicrobial activity and DNA cleavage analysis have also been studied and reported.
Introduction
Human Immunodeficiency Virus (HIV) is a retrovirus of lentivirus family and contains a reverse transcriptase (RT) enzyme responsible for making a DNA copy of the viral RNA. This virus attacks human cell and attach to CD4 and chemokine receptors on the membrane and release RNA to the cytoplasm. Reverse transcriptase catalyzes this process and help in DNA synthesis. Thus RT plays a crucial role in virus survival and cell progression. Intensive studies of this enzyme by researchers have attracted our interest to inhibit proliferation of HIV cell. Wide variety of drugs has been developed for HIV based on these studies is available in market. These HIV-1 drugs are divided in nucleoside (NRTIs, AZT, e.g., 3TC, and ddC) and non-nucleoside (NNRTIs e.g., nevirapine, delaviridine) reverse transcriptase inhibitors [1] [2] [3] [4] [5] . Non-nucleoside inhibitors are most widely used for the treatment of HIV-1-infection 6 . 8 The rapid development of resistance to these available drugs by HIV cell has diminished the effectiveness of current approved NNRTIs in the market, leading to urgent need of next generation NNRTIs. Large number of computation methods have been reported to find new drug candidate, this are based on Quantitative structure-activity relationship (QSAR) techniques. This technique correlates biological activity to their physicochemical properties 7 .
It is necessary to study the accurate physicochemical and biological properties using QSAR techniques. QSAR data obtained from various research works confirm the docking of NNRTIs to a specific allosteric non-substrate binding pocket site (Non-nucleoside binding pocket-NNBP 8 . A number of Pharmacophore modeling studies have been performed to find out the better inhibitor of RT. It helps medicinal chemist to filter out the active ingredients before synthesis. Various properties of drug affect their activity like solubility, hydrophobicity, PSA (Polar Surface Area), and steric factor. In silico studies by various computer applications help in determining this parameter using virtual screening 9, 10 . QSAR studies on metal compounds have also been probed for potential anti-HIV therapeutic actions. Some study reports metal based anti-viral compounds like, ruthenium complex Na7-[Ru4(l-O)4(C2O4)6], eilatin ruthenium complexes, and oxovanadium(IV) porphyrin complexes possess anti-HIV-1 activity 11, 13 .
A study on Gold cyanide, [Au(CN)2] -complex was reported as anti-HIV agent acting by inhibiting RT 14 . A wide variety of amidine compounds have been found to be active against viral, fungal and bacterial diseases. Amidine are the Schiff base derivatives have wide variety of biological activities thus used in viral fungal and bacterial disease 15 . Some metal complexes of amidine have been synthesized and evaluated their antimicrobial and antitumoral activity 16, 17 . In order to gain further insights, we have carried out in vitro inhibition of reverse transcriptase (RT) enzyme from HIV cell. The present article describe the synthesis of Zn(II), Cr(II) and Co(II) complexes (3-5) of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine (2) biological evaluation as reverse transcriptase inhibitors from HIV type-1.
Results and Discussion

Spectral studies
2.1.1.
1 H NMR spectral studies 1 H NMR spectra of ligand (2) displayed distal hydroxyl proton H-14 peak at 10.93 ppm and H-2, H-6, H-5 and H-1 protons of benzene ring at 7.39-7.47 ppm as doublet of doublet. Distal H-12 (free hydrogen) proton appeared at 7.82 ppm as singlet, confirming the structure of ligand (2) (Figure 1) . A singlet was observed at 5.99 ppm assigned for (C=NH) protons of hydroxyamidine moiety. Peak at 9.88 ppm was assigned for (=N-OH) proton. As the formation of metal complexes many changes were observed in the chemical shifts, it was confirmed by the disappearance of amidine hydroxyl (-OH) proton. In all metal complexes of Zn(II), Co(II) and Cr(II), (Ar-CH3) protons remains its position. A singlet of (=C-NH2) proton was observed lower downfield at 1.50 ppm than ligand (2). H-11, H-12, H-14 and H-15 showed multiplate between 7.90-7.97 ppm of aromatic ring (Figure 1) . Distal proton was observed at 8.07 and 8.29 ppm. A singlet was observed for distal hydroxyl group H-24 at 10.93 ppm. Distal (N-OH) was observed at 10.91 and 10.93 ppm for Zn(II) and Co(II) complex respectively. Similarly (H-C=N) was showed at 8.29 and 8.25 ppm for Cr(II) and Zn(II) complex. Furthermore, the number of the proton calculated from the integration curves and those obtained from the values of the expected CHN analysis agreed well with each other. 1 H NMR spectra of HIMB ligand (2) and its Co(II) complex (4).
13 C NMR spectral studies
13 C NMR spectra of ligand (2) displayed the entire characteristic peak at the expected position which further supported the results obtained in IR and 1 H NMR. The C2 and C6 carbons of ligand (2) containing showed shift at 130.24 ppm, similarly C1 and C5 carbon gives shifting peak downward at 128.78 ppm, due to the sharing of electron of nitrogen towards the benzene ring system. Amidine moiety containing C7 were assigned at more downfield 153.10 ppm due to deshielding effect. Another characteristic peak of distal C11 was observed at 149.34 ppm. As the complexes were formed many changes in chemical shifting were found. Amandine carbon C5 and C8 were shifted to some higher downfield at 149.34 ppm than ligand (2) due to increase in electron cloud and hence hindrance. Ring carbon C18 and C10 attached to amidine moiety (C5 and C8) showed only a slight shifting at position 129.60 ppm, due to increase in electron cloud on metal coordination. Aromatic carbon C13, C14 and C12 attached to iminomethyl group was observed at 130.74 ppm, and the carbon C27 of iminomethyl group at 149.34 ppm. Other carbon in amidine moiety was observed at 152.99 ppm. Furthermore, the number of carbons calculated from the integration curve and those obtained from the values of the expected CHN analyses agree well with each other.
IR spectral investigations
The IR spectra of the complexes have been examined in comparison with the spectra of the Nhydroxy-4-[(hydroxyimino)methyl]benzamidine ligand (2). IR spectra of the ligand (2) in particular show main characteristic absorptions in the range 1653, 972, 2914, 3495 and 3292 cm -1 , which can be assigned to C=N, NO, C-N, distal OH and amidine OH stretching vibrations, respectively. 
Electronic spectra and magnetic moments
The UV absorption spectra of ligand (2) and its complexes at very low concentrations are recorded in the wavelength range 200-700 nm using a VARIAN UV-Vis spectrophotometer. It was seen that ligand (2) display peaks at around 260 nm, corresponding to π-π* transition due to phenyl ring. Another characteristic peak at 350 nm was observed due to n-π* transition of C=N group. As the complex formed many changes were seen. In the Zn(II) complex blue shift were seen, the higher energy spectra of the complex was shown at 250 and 310 nm correspond to the ligand (2) π-π* transition and ligand (2) to metal charge transfer π-π* transition.
Ligand (2)
Cr ( A low energy spectrum was observed at 420 nm and maximum wavelength due to ligand (2) to metal charge transfer. The electronic spectra of Cr(II) and Co(II) complexes were also studied and found many peaks correspond to various transitions. The absorption peak at 240 and 210 nm due to ligand (2) π-π* transition in Co(II) and Cr(II) complexes respectively in the UV region (Figure 2 ). An n-π* transition was confirmed by the absorption peak at 280-300 nm correspond to C=N, which shifted towards the lower wavelength and higher energy on coordination with metal ions. Magnetic moment of Co(II) complex was observed 1.7 BM which is characteristic of low spin d 7 ions in octahedral field. The ligand (2) to metal charge transfer was observed at 500 nm in Co(II) complex and 420 nm in Cr(II) complex a low energy d-d transition was observed at 600 nm (high energy) and 580 nm (low energy) in Co(II) and Cr(II) complex respectively, confirming there octahedral geometry. The magnetic moment observed for Cr(II) complex is quite low (2.9 BM) for d 4 ions in octahedral field. This value could be caused by significant distortion from ideal geometry, which leads to a fall in the orbital contribution to the magnetic moment.
Mass spectral studies
The mass spectral characterization of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine and its Zn(II), Cr(II) and Co(II) complexes were performed to confirm their orientation. The molecular ion peak at m/z 179. 10 
Thermo gravimetric analysis (TGA)
The thermal properties of the ligand (2) and its metal complexes were investigated by thermal gravimetric analysis (TGA). 
Biological study 2.2.1. DNA cleavage study
DNA cleavage activity of prepared compounds was analyzed by monitoring the conversion of supercoiled DNA (Form I) to nicked DNA (Form II) and linear DNA (Form III) under anaerobic conditions. No DNA cleavage was found for the lane 1 and Lane 2 which incorporates with the DNA control and (DNA + H2O2) respectively (Fig. 5) . It was observed that ligand (2) at 70 μM concentration can induce almost 80% supercoiled DNA to linear and nicked DNA (lane 3). It was observed that Cr(II) and Co(II) complexes can almost promote 65% cleavage at their maximum concentration of 50 μM. At lower concentration no cleavage was observed for these complexes. No significant conversion of CTDNA was observed for Zn(II) complex up to their maximum concentration of 50 μM. 
Antifungal activity
The antifungal activities of all compounds were tested against T.longifusus, C.albican, A.flavus and P.carinii fungal strain. It was observed that Cr(II) and Co(II) complexes showed significant activity against T.longifusus (MIC-75 µM/ml). All the compounds were active against C.albican except Zn(II) complex, but Co(II) showed good activity (MIC-208 µM/ml). The Cr(II) complex was not active against ( Table 2, Fig. 6 ), highest activity was observed for Co(II) complex (MIC-100 µM/ml). Only Zn(II) and Co(II) complexes showed activity against A.flavus, but Co(II) complex was showed significant activity (MIC-50 µM/ml). All the compounds showed weak to moderate activity against P.carinii, but ligand (2) showed significant activity (MIC-90 µM/ml) compared to those of standard drug miconazole (Table 3) . Two tautomeric analogues of HIMB ligand (2) are proposed which is responsible for antimicrobial activity. Thus the charge is distributed; it could generate the in situ presence of antibacterial and antifungal activity (Fig. 4) . 
Antibacterial activity
The N-hydroxy-4-[(hydroxyimino)methyl]benzamidine and their metal ion complexes were synthesized, characterized and their antibacterial activity were studied against four selected bacterial strain B.subtilis, S.aureus, B.cereus and S.pneumoniae. All the compounds showed varying degree of inhibitory activity against selected species. All the prepared compounds have potent activity against B.subtilis as compared to standard drug Ampicillin (Table 3, Fig. 7 ), but best activity was recorded of ligand (2) (MIC-25 µM/ml). All the complexes showed almost similar activity against S.pneumoniae, but Cr(II) and Zn(II) complexes are most active (MIC ~ 36 µM/ml). A weak to excellent activity was exhibited by all compounds against S.aureus whereas Cr(II) complex showed excellent activity. The Co(II) complex showed maximum activity against the growth of B.cereus (Table 4) , where moderate activity was observed of other compounds. The antibacterial activities of all the compounds are very much interesting and may lead as multi target drug. Table 3 . Zone of inhibition of HIMB ligand (2) and their metal ion complexes against selected bacterial species HIMB  20  16  14  25  15  20  -26  HIMBZn  18  11  20  28  -12  19  16  HIMBCo  15  23  16  30  30  28  27  13  HIMBCr  15  26  19  29  23  --10  Miconazole ----10  23  26  30  Ampicillin  29  22  28 
Compounds Bacterial zone of inhibition, in mm Fungal zone of inhibition, in mm B.subtilis S.aureus B.cereus S.pneumoniae T.longifusus C.albican A.flavus P.carinii
In vitro study of cell viability
To test the toxicity of our compounds against the peripheral blood mononuclear cells, we chose only ligand (2) and Zn(II) which are most active against RT. We prepared 50-500 nM concentration of ligand (2) and Zn(II) complex and tested their toxicity by cell viability test using MTT. We observed that ligand (2) was toxic above 500 nM and Zn(II) complex was toxic above 350 nM. The % cell viability at different concentration is shown in the Table 5 , delaviridine was used as control. It was concluded that both compounds do not show toxicity to the immune system at low concentration only toxic at higher concentration. Table 5 . Percentage viability test of HIMB ligand (2) and their Zn(II) complex on peripheral blood mononuclear cells. HIMBZn  Control  50  101  96  100  100  99  98  98  250  96  110  95  350  101  60  100  400  105  10  105  500  70  0  99  550  30  0  98 Control -Delaviridine; PBMC-Peri pheral bl ood mon onucl ear cell
Concentration (nM) % Viability of PBMC HIMB
Reverse transcriptase inhibition assay
Reverse transcriptase is an important enzyme of HIV cell to help in synthesis of genetic materials. We have synthesized Cr(II), Co(II) and Zn(II) complexes of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine and studies their activity on reverse transcriptase using enzyme assay technique. The results were compared with those of standard drugs delaviridine. The percentage inhibition and inhibitory concentration at 50% (IC50) of all compounds were observed and tabulated. The ligand (2) and Zn(II) complex showed the moderate activity ( Table 6, Fig. 8 ), but Cr(II) and Co(II) complexes exhibited no activity against reverse transcriptase. HIMB ligand (2) displayed 45% inhibition at IC50 ~ 450 nM and Zn(II) complex can inhibit the growth up to 53% at IC50 ~ 250 nM. The observation shows the hydrogen bond donor and acceptor properties of ligand (2) and Zn(II) complex. The amidine moiety, distal hydroxyl group and coordination to Zn(II) metal ion is responsible for activity of ligand (2) and Zn(II) complex. The physicochemical data of ligand (2) displayed good solubility and OH-NH interaction to amino acid residues support inhibitory activity of ligand (2). 
IC50 (nM) Compounds
The tetrahedral geometry of Zn(II) complex allows higher number of hydrogen bonding in the active site of RT increases their inhibitory activity. Another factor responsible for activity of Zn(II) complex against reverse transcriptase is their hydrophilicity and good solubility. It was studied that the higher permeability and hydrogen bonding increases their potencies. The present results show that ligand (2) and Zn(II) complex may be further studied increase their potencies for the future to control HIV-1. The Co(II) and Cr(II) complexes were studied and found as inactive against Reverse Transcriptase, although the activity was related to metal toxicity. These results were confirmed by separate studies of ligand, metal ions and metal complexes. The octahedral geometry and steric hindrance of Cr(II) and Co(II) complexes restricts approaching to the active site of RT so the activity diminished, the only inhibition was observed by preparing separate metal ion solutions which showed the metal toxicity.
Conclusions
The biological properties of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine and its Zn(II), Co(II) and Cr(II) complexes showed good activity against selected fungal and bacterial species, also DNA cleavage activity. The possible tautomeric analogues of HIMB ligand (2) and tetrahedral geometry of Zn(II) complex furnish enhanced antimicrobial activity against B.subtilis and S.aureus . The ligand (2) and their Zn(II) complex were found more active against reverse transcriptase with the same reason as the antimicrobial activity. The highest activity of Co(II) and Cr(II) complexes were found against B.subtilis, B.cereus and P.carinii incorporated with higher permeability from cell wall of microbes. The solubility and steric factor is involved in RT inhibitory activity, considering this phenomenon may lead, we assume that HIMB ligand (2) and Zn(II) complex on proper study may lead as active anti HIV-1 as well as antimicrobial agents.
Experimental
Materials and methods
All the compounds were prepared and purified using AR grade reagents using the below mentioned procedures.
Synthesis of ligand (2) and its metal(II) complexes
Synthesis of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine ligand (HIMB) (2)
N-hydroxy-4-[(hydroxyimino)methyl]benzamidine was synthesized (Scheme 1) using known procedure reported elsewhere 18 . In a 250 ml conical flask, 4-[(hydroxyimino)methyl]benzonitrile, 2 g (0.012 mole), NH2OH.HCl, 1.39 g (0.2 mole) and NaNO3 1.02 g (0.012 mole) was mixed, 80 ml water/ ethanol (2:1) was added to this mixture and stirred using magnetic stirrer followed by reflux for 2.5 hr. After completion of reaction solution was cooled to room temperature, crystals of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine were separated out. Solvent was removed under reduced pressure, recrystallized using ethanol and followed by diethyl ether. Thin layer chromatography was used to check the purity. 
Synthesis of N-hydroxy-4-[(hydroxyimino)methyl]benzamidine metal(II) complexes
Metal complexes were prepared by mixing methanolic solution of ligand (2) and metal salt in 1:2 (L:M) ratio. Ligand (2) was taken in 250 ml conical flask and metal salt were added drop wise using magnetic stirrer. The final solution was then transferred into a 250 ml round bottom flask and refluxed for 2 hr using water bath. Solution was cooled at room temperature, crystals of metal complexes were separated, filtered and recrystallized using ethanol, dried under vacuum. 
Physical and Spectral Data
N-hydroxy-4-[(hydroxyimino)methyl]benzamidine (HIMB) ligand (2)
Yield
N-hydroxy-4-[(hydroxyimino)methyl]benzamidine Zn(II) complex (HIMBZn) (3)
Yield: 65%; Color: (yellowish powder); m. 
N-hydroxy-4-[(hydroxyimino)methyl]benzamidine Co(II) complex (HIMBCo) (4)
In vitro antifungal activity
The antifungal efficacy of the prepared compounds was tested against T.longifusus, C.albican, A.flavus and P.carinii fungal species using the protocol mentioned in the literature 21 . All fungi were cultured in agar medium and incubated at 36 o C for 48 hr. The incubation chamber was kept humid. At the end of the incubation period, minimum inhibitory concentration (MIC) and zone of inhibition of all compounds against fungal species were recorded. Results were compared with the standard drug miconazole.
DNA cleavage activity
Ligand (2) and its metal complexes were studied to evaluate their nucleage activity of DNA using agarose gel electrophoresis 22 . Experiment was initiated by incubation of the solution containing 30 µM CT-DNA, 50-70 µM test samples and 50 µM hydrogen peroxide (H2O2) in Tris-HCl/NaCl buffer (pH 7.2) at 37 o C for 2 hr. After incubation, the solutions were electrophoresed for 2 hr. at 50V on 1% agarose gel in Tris-acetic acid-EDTA buffer (pH 7.2); ethidium bromide 1 µg cm −3 was used as staining agent. DNA cleavage activity of all compounds was measured using documentation chamber 23 .
Cell viability test
Cell viability test of active compounds (HIMB and Zn(II) complex) on uninfected peripheral blood mononuclear cells were performed by MTT assay. Blood cells were taken in 80 wells plates and compounds were added in the concentration range of 50-500 nM. Culture was maintained at 37 o C under 5% CO2 for 10 days. An aliquot of 30 µl MTT solution was added to it and the plated were read after 24 hr. Viable tissue produces formazan crystals which are solubilized with methanol according to the procedure reported elsewhere 24, 25 . Tissue viability was determined by dividing the optical density at 570 nm of the formazan product.
In vitro reverse transcriptase inhibition assay
To test the reverse transcriptase inhibition activity of HIMB ligand ( 
